RecruitingNCT06624865

Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors


Sponsor

Hospices Civils de Lyon

Enrollment

75 participants

Start Date

Nov 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient with one or more small-intestine neuroendocrine tumor with indication of surgery
  • Patient with consent for the collection, storage and reuse of data associated with his/her disease
  • Age ≥ 18 years at the time of inclusion
  • Non-objection statement obtained for participation in the study

Exclusion Criteria5

  • Patients with poorly differentiated neuroendocrine carcinoma or NET (neuroendocrine tumors) of non-intestinal origin or mixed tumors (MiNEN)
  • Pregnant, parturient or breast-feeding women
  • Minors
  • Persons deprived of liberty by judicial or administrative decision
  • Adults under legal protection (guardianship, curatorship)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood and stool sampling

Blood and stool sampling


Locations(1)

Edouard Herriot University Hospital

Lyon, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624865